The overall objectives of the Clinical Research Core (CRC) over the next 5 years are to promote and support clinical HIV research in the Pacific Northwest region through: 1) Recruitment and referral of HIV-infected persons into clinical research protocols to increase the productivity of these funded studies, 2) Expansion of the UW HIV Specimen Repository to support translational clinical and pathogenesis research and 3) Expansion of the Study Assistance and Specimen Collection Service to aid investigators in the enrollment and implementation of their HIV research protocols Recruitment and referral of potential research subjects will be performed by a dedicated research referral nurse who screens all UW Registry patients cared for at the UW HIV clinics, identifies eligible patients based on study criteria and refers patients to study coordinators for enrollment. Expansion of the UW HIV Specimen Repository will be accomplished by continued, targeted enrollment of HIV+ subjects at the UW HIV clinics and linkage to other research groups such as the CFAR Network of Integrated Systems (C-NICS) and the Kampala HIV discordant couples study. Increased utilization of the Repository will continue due to enhanced CRC advertising efforts and since the Repository has now reached a size sufficient to accommodate investigator requests. Expansion of the Study Assist and Specimen Collection Service will be possible due to the increased expertise of CRC staff, the availability of space (examination room) and resources (office equipment, freezers, liquid nitrogen tanks) and the enhanced advertisement of these services to regional investigators. These activities will tightly link the CRC to the Clinical Epidemiology and Health Services Research, Clinical Retrovirology, Developmental, International and Sociobehavioral and Prevention Cores, all the UW CFAR Institutions (Fred Hutchinson Cancer Center, Seattle Biomedical Research Institute, UW School of Medicine, Children's Hospital and Regional Medical Center) and other local and national research groups. These strategies serve to augment existing funded research programs that depend on successful accrual of patients and access to patient specimens. This value-added approach directly supports the large, diverse HIV research programs that exist at the University of Washington, and provides ready access to HIV infected patients, patient specimens and the clinical resources needed to implement clinical studies. These efforts advance the clinical HIV research agendas of local and national HIV investigators and contribute to the fight against HIV and AIDS by providing researchers with the clinical resources needed to conduct their investigations. These resources include access to potential research subjects, patient specimens (such as blood components) and the space and tools needed to perform their research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027757-23
Application #
8080964
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-05-31
Support Year
23
Fiscal Year
2010
Total Cost
$184,687
Indirect Cost
Name
University of Washington
Department
Type
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Bengtson, Angela M; Pence, Brian W; Eaton, Ellen F et al. (2018) Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015. Antivir Ther 23:363-372
Fredericksen, Rob J; Mayer, Kenneth H; Gibbons, Laura E et al. (2018) Development and Content Validation of a Patient-Reported Sexual Risk Measure for Use in Primary Care. J Gen Intern Med 33:1661-1668
Wilson, Kate S; Wanje, George; Masese, Linnet et al. (2018) A Prospective Cohort Study of Fertility Desire, Unprotected Sex, and Detectable Viral Load in HIV-Positive Female Sex Workers in Mombasa, Kenya. J Acquir Immune Defic Syndr 78:276-282
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Gómez, Laurén A; Crowell, Claudia S; Njuguna, Irene et al. (2018) Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children. Pediatr Infect Dis J 37:916-922
Ikoma, Minako; Gantt, Soren; Casper, Corey et al. (2018) KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite. PLoS One 13:e0192659
Lohman-Payne, Barbara; Gabriel, Benjamin; Park, Sangshin et al. (2018) HIV-exposed uninfected infants: elevated cord blood Interleukin 8 (IL-8) is significantly associated with maternal HIV infection and systemic IL-8 in a Kenyan cohort. Clin Transl Med 7:26
McGrath, Christine J; Singa, Benson; Langat, Agnes et al. (2018) Non-disclosure to male partners and incomplete PMTCT regimens associated with higher risk of mother-to-child HIV transmission: a national survey in Kenya. AIDS Care 30:765-773
Thomson, Kerry A; Dhanireddy, Shireesha; Andrasik, Michele et al. (2018) Fertility desires and preferences for safer conception strategies among people receiving care for HIV at a publicly-funded clinic in Seattle, WA. AIDS Care 30:121-129
Stone, Mars; Bainbridge, John; Sanchez, Ana M et al. (2018) Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates. J Clin Microbiol 56:

Showing the most recent 10 out of 1275 publications